- Supplementary Figure S1[supplements/301397_file03.pdf]
- Supplementary Figure S2[supplements/301397_file04.pdf]
- Supplementary Figure S3[supplements/301397_file05.pdf]
- Supplementary Table S1[supplements/301397_file06.docx]
- Supplementary Table S2[supplements/301397_file07.docx]
- Supplementary Table S3[supplements/301397_file08.docx]
- Supplementary Table S4[supplements/301397_file09.docx]
- Supplementary Table S5[supplements/301397_file10.docx]
- Supplementary Table S6[supplements/301397_file11.docx]
- Supplementary Table S7[supplements/301397_file12.docx]
- Supplementary Table S8[supplements/301397_file13.docx]
- Supplementary Table S9[supplements/301397_file14.docx]
- Supplementary Table S10[supplements/301397_file15.docx]
- Supplementary Table S11[supplements/301397_file16.docx]
Posted February 09, 2024.
Comparative effectiveness of ARB and ACEi for cardiovascular outcomes and risk of angioedema among different ethnic groups in England: an analysis in the UK Clinical Practice Research Datalink with emulation of a reference trial (ONTARGET)
